From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy. - Pinto E; Lione L; Compagnone M; Paccagnella M; Salvatori E; Greco M; Frezza V; Marra E; Aurisicchio L; Roscilli G; Conforti A (Journal of translational medicine, 2025)